Visceral leishmaniasis (VL) is a major vector-borne disease caused by Leishmania donovani, after replication of the parasites in macrophages, mononuclear phagocytic system. VL is endemic in 12 districts of central and eastern Terai lowlands of Nepal bordering North Bihar, India with an estimated 8 million population at risk. In addition, VL endemicity is also extending to new endemic regions like Dharan from its classical rural foci. Hence, we aimed to detect the evidence of Leishmania donovani infection in the blood samples received from blood donors of Sunsari district, Dharan, (eastern Nepal), a region endemic for human VL. Sera from 507 asymptomatic blood donors were subjected to serological screening for anti-Leishmania donovani antibodies. Direct agglutination test (DAT) was performed on the sera. Out of 507 donors, majority (78.50 %) were male. Among the donors, 472 (93.10 %) belonged to age group 18–45 years where as 35 (6.90 %) to age group >45 years. Circulating anti-Leishmania antibodies were detected in 5 (1 %) out of 507 healthy, Human Immunodeficiency Virus types 1 and 2 (HIV 1and 2), Hepatitis B Surface Antigen (HBsAg), anti- Hepatitis C Virus (anti-HCV)-negative, and Syphillis non-reactive donors. All the seropositive cases were male and belonged to the age group 18–45 years. The result suggests that there is an immediate need of screening asymptomatic blood donors for leishmania seropositivity especially in endemic areas.
Asymptomatic blood donors DAT Dharan Visceral leishmaniasis
This is a preview of subscription content, log in to check access.
We are sincerely thankful to the technical staffs of Department of Microbiology, BPKIHS, Dharan, in helping us to conduct this work. In addition, we are grateful to the staffs of Blood Bank, Dharan for their continuous help and support.
Bista MB (1998) National overview of kala-azar in Nepal. In: Bastola S, Karki P, Rijal S, Gautam A (eds) Kala-azar in Nepal: principals, practice and public health perspectives. EDCD/BPKIHS/WHO, Kathmandu, pp 1–5Google Scholar
Rijal S, Uranw S, Chappuis F et al (2010) Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal. Trop Med and Int Health 15(2):21–28CrossRefGoogle Scholar
Chappuis F, Sundar S, Hailu A et al (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5:873–882CrossRefPubMedGoogle Scholar
Xavier B (2003) USA blocks blood donation in bid to prevent leishmaniasis. Lanc Infect Dis 3:746Google Scholar
Meredith SE, Kroon NC, Sondorp E et al (1995) Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis. J Clin Microbiol 33:1742–1745PubMedCentralPubMedGoogle Scholar
Boelaert M, Rijal S, Regmi S et al (2004) A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis. Am J Trop Med Hyg 70:72–77PubMedGoogle Scholar
Zijlstra EE, El-Hassan AM, Ismael A et al (1994) Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg 51:826–836PubMedGoogle Scholar
Hasker E, Malaviya P, Gidwani K et al (2014) Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal. PLoS Negl Trop Dis 5:e1405. doi:10.1371/journal.pntd.0002657Google Scholar
Scarlata F, Vitale F, Saporito L, Reale S et al (2008) Asymptomatic Leishmania infantum/chagasi infection in blood donors of western Sicily. Trans R Soc Trop Med Hyg 102:394–396CrossRefPubMedGoogle Scholar
Fakhar M, Motazedia MH, Hatam GR et al (2008) Asymptomatic human carriers of Leishmania infantum: possible reservoirs for Mediterranean visceral leishmaniasis in southern Iran. Ann Trop Med Parasitol 102:577–583CrossRefPubMedGoogle Scholar
Riera C, Fisa R, Udina M et al (2004) Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Islands, Spain) by different diagnostic methods. Trans R Soc Trop Med Hyg 98:102–110CrossRefPubMedGoogle Scholar
Le Fichoux Y, Quaranta JF, Aufeuvre JP et al (1999) Ocurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in Southern France. J Clin Microbiol 37:1953–1957PubMedCentralPubMedGoogle Scholar
Luz KG, da Silva VD, Gomes EM et al (1997) Prevalence of anti-leishmania donovani antibody among brazilian blood donors and multiply transfused hemodialysis patients. Am J Trop Med Hyg 57(2):168–171PubMedGoogle Scholar
Riera C, Fisa R, López-Chejade P et al (2008) Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain). Transfus 48:1383–1398CrossRefGoogle Scholar
Antinori S, Cascio A, Parravicini C et al (2008) Leishmaniasis among organ transplant recipients. Lancet Infect Dis 8:191–199CrossRefPubMedGoogle Scholar
Dey A, Singh S (2006) Transfusion transmitted leishmaniasis: a case report and review of the literature. Indian J Med Microbiol 24:165–170PubMedGoogle Scholar
Kyriakou DS, Alexandrakis MG, Passam FH et al (2003) Quick detection of Leishmania in peripheral blood by flow cytometry. Is prestorage leucodepletion necessary for leishmaniasis prevention in endemic areas? Transfus Med 13(2):59–62CrossRefPubMedGoogle Scholar